Adiponectin alters renal calcium and phosphate excretion through regulation of klotho expression

Kidney International

Volumn 91, Issue 2, 2017, Pages 324-337

  Rutkowski, Joseph M ^a   Pastor, Johanne ^b,c   Sun, Kai ^a   Park, Sun K ^b,c   Bobulescu, I Alexandru ^b,c   Chen, Christopher T ^b,c   Moe, Orson W ^b,c   Scherer, Philipp E ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

calcium; FGF23; mineral metabolism; obesity; phosphate

Indexed keywords

ADIPONECTIN; CALCIUM; CALCIUM ION; DOXYCYCLINE; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; PHOSPHATE; ADIPOQ PROTEIN, MOUSE; BETA GLUCURONIDASE; CALCIUM INTAKE; COLLAGEN; FIBROBLAST GROWTH FACTOR; HORMONE; PHOSPHATE INTAKE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MASS; BONE STRENGTH; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM INTAKE; CONTROLLED STUDY; EMBRYO; EPITHELIUM CELL; HORMONE DETERMINATION; HUMAN; IN VITRO STUDY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY TUBULE EXCRETION; MALE; MOUSE; NONHUMAN; PHOSPHATE BLOOD LEVEL; PHOSPHATE EXCRETION; PHOSPHATE INTAKE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WILD TYPE MOUSE; ANIMAL; BIOMECHANICS; BLOOD; BONE DEVELOPMENT; DEFICIENCY; DOG; FEMUR; FIBROSIS; GENETIC TRANSFECTION; GENETICS; GENOTYPE; HOMEOSTASIS; KIDNEY; KIDNEY TUBULE; KNOCKOUT MOUSE; MDCK CELL LINE; METABOLISM; PATHOLOGY; PHENOTYPE; SPINE; URINARY EXCRETION; URINE;

ADIPONECTIN; ANIMALS; BIOMECHANICAL PHENOMENA; CALCIUM, DIETARY; COLLAGEN; DOGS; FEMUR; FIBROBLAST GROWTH FACTORS; FIBROSIS; GENOTYPE; GLUCURONIDASE; HOMEOSTASIS; HORMONES; KIDNEY; KIDNEY TUBULES; MADIN DARBY CANINE KIDNEY CELLS; MALE; MICE, KNOCKOUT; OSTEOGENESIS; PHENOTYPE; PHOSPHATES; PHOSPHORUS, DIETARY; RENAL ELIMINATION; SPINE; TRANSFECTION;

EID: 85007448597     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.09.016     Document Type: Article

References (47)

1. Rutkowski, J.M., Stern, J.H., Scherer, P.E., The cell biology of fat expansion. J Cell Biol 208 (2015), 501–512.
2. Ye, R., Scherer, P.E., Adiponectin, driver or passenger on the road to insulin sensitivity?. Mol Metab 2 (2013), 133–141.
3. Mather, K.J., Goldberg, R.B., Clinical use of adiponectin as a marker of metabolic dysregulation. Best Pract Res Clin Endocrinol Metab 28 (2014), 107–117.
4. Asterholm, I.W., Scherer, P.E., Enhanced metabolic flexibility associated with elevated adiponectin levels. Am J Pathol 176 (2010), 1364–1376.
5. Holland, W.L., Miller, R.A., Wang, Z.V., et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17 (2011), 55–63.
6. Nawrocki, A.R., Rajala, M.W., Tomas, E., et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281 (2006), 2654–2660.
7. Ohashi, K., Iwatani, H., Kihara, S., et al. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol 27 (2007), 1910–1917.
8. Rutkowski, J.M., Wang, Z.V., Park, A.S., et al. Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrol 24 (2013), 268–282.
9. Sharma, K., Ramachandrarao, S., Qiu, G., et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118 (2008), 1645–1656.
10. Halberg, N., Schraw, T.D., Wang, Z.V., et al. Systemic fate of the adipocyte-derived factor adiponectin. Diabetes 58 (2009), 1961–1970.
11. Rutkowski, J.M., Halberg, N., Wang, Q.A., et al. Differential transendothelial transport of adiponectin complexes. Cardiovasc Diabetol, 13, 2014, 47.
12. Cammisotto, P.G., Londono, I., Gingras, D., et al. Control of glycogen synthase through ADIPOR1-AMPK pathway in renal distal tubules of normal and diabetic rats. Am J Physiol Renal Physiol 294 (2008), F881–F889.
13. D'Apolito, M., Du, X., Zong, H., et al. Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Invest 120 (2010), 203–213.
14. Iwashima, Y., Horio, T., Kumada, M., et al. Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol 98 (2006), 1603–1608.
15. Martinez Cantarin, M.P., Waldman, S.A., Doria, C., et al. The adipose tissue production of adiponectin is increased in end-stage renal disease. Kidney Int 83 (2013), 487–494.
16. Ahmadian, M., Suh, J.M., Hah, N., et al. PPARgamma signaling and metabolism: the good, the bad and the future. Nat Med 19 (2013), 557–566.
17. Billington, E.O., Grey, A., Bolland, M.J., The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis. Diabetologia 58 (2015), 2238–2246.
18. Kajimura, D., Lee, H.W., Riley, K.J., et al. Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1. Cell Metab 17 (2013), 901–915.
19. Kanazawa, I., Adiponectin in metabolic bone disease. Curr Med Chem 19 (2012), 5481–5492.
20. Wang, Q.P., Li, X.P., Wang, M., et al. Adiponectin exerts its negative effect on bone metabolism via OPG/RANKL pathway: an in vivo study. Endocrine 47 (2014), 845–853.
21. Ealey, K.N., Kaludjerovic, J., Archer, M.C., et al. Adiponectin is a negative regulator of bone mineral and bone strength in growing mice. Exp Biol Med 233 (2008), 1546–1553.
22. Wu, Y., Tu, Q., Valverde, P., et al. Central adiponectin administration reveals new regulatory mechanisms of bone metabolism in mice. Am J Physiol Endocrinol Metab 306 (2014), E1418–E1430.
23. Williams, G.A., Wang, Y., Callon, K.E., et al. In vitro and in vivo effects of adiponectin on bone. Endocrinology 150 (2009), 3603–3610.
24. Khan, M.P., Singh, A.K., Joharapurkar, A.A., et al. Pathophysiological mechanism of bone loss in type 2 diabetes involves inverse regulation of osteoblast function by PGC-1alpha and skeletal muscle atrogenes: adipoR1 as a potential target for reversing diabetes-induced osteopenia. Diabetes 64 (2015), 2609–2623.
25. Hu, M.C., Shiizaki, K., Kuro-o, M., et al. Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Ann Rev Physiol 75 (2013), 503–533.
26. Carrasco, F., Basfi-Fer, K., Rojas, P., et al. Changes in bone mineral density after sleeve gastrectomy or gastric bypass: relationships with variations in vitamin D, ghrelin, and adiponectin levels. Obes Surg 24 (2014), 877–884.
27. Wright, O.R., Hickman, I.J., Petchey, W.G., et al. The effect of 25-hydroxyvitamin D on insulin sensitivity in obesity: is it mediated via adiponectin?. Can J Physiol Pharmacol 91 (2013), 496–501.
28. Holland, W.L., Adams, A.C., Brozinick, J.T., et al. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab 17 (2013), 790–797.
29. Lin, Z., Tian, H., Lam, K.S., et al. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab 17 (2013), 779–789.
30. Combs, T.P., Pajvani, U.B., Berg, A.H., et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145 (2004), 367–383.
31. Hu, M.C., Shi, M., Zhang, J., et al. Renal production, uptake, and handling of circulating alphaKlotho. J Am Soc Nephrol 27 (2015), 79–90.
32. Hu, M.C., Shi, M., Zhang, J., et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22 (2011), 124–136.
33. Hu, M.C., Shi, M., Cho, H.J., et al. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. J Am Soc Nephrol 26 (2015), 1290–1302.
34. Ito, N., Wijenayaka, A.R., Prideaux, M., et al. Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli. Mol Cell Endocrinol 399 (2015), 208–218.
35. Pan, X., Small, E.V., Igarashi, P., et al. Generation and characterization of KsprtTA and KsptTA transgenic mice. Genesis 51 (2013), 430–435.
36. Lo, M.M., Salisbury, S., Scherer, P.E., et al. Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease. Pediatr Nephrol 26 (2011), 2009–2017.
37. Sharma, K., Obesity, oxidative stress, and fibrosis in chronic kidney disease. Kidney Int Suppl 4 (2014), 113–117.
38. Jin, X., Chen, J., Hu, Z., et al. Genetic deficiency of adiponectin protects against acute kidney injury. Kidney Int 83 (2013), 604–614.
39. Yang, J., Lin, S.C., Chen, G., et al. Adiponectin promotes monocyte-to-fibroblast transition in renal fibrosis. J Am Soc Nephrol 24 (2013), 1644–1659.
40. Ding, X., Boney-Montoya, J., Owen, B.M., et al. betaKlotho is required for fibroblast growth factor 21 effects on growth and metabolism. Cell Metab 16 (2012), 387–393.
41. Lee, P., Linderman, J., Smith, S., et al. Fibroblast growth factor 21 (FGF21) and bone: is there a relationship in humans?. Osteoporos Int 24 (2013), 3053–3057.
42. Mirza, M.A., Alsio, J., Hammarstedt, A., et al. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals. Arterioscler Thromb Vasc Biol 31 (2011), 219–227.
43. Wang, Z.V., Deng, Y., Wang, Q.A., et al. Identification and characterization of a promoter cassette conferring adipocyte-specific gene expression. Endocrinology 151 (2010), 2933–2939.
44. Barker, S.L., Pastor, J., Carranza, D., et al. The demonstration of alphaKlotho deficiency in human chronic kidney disease with a novel synthetic antibody. Nephrol Dial Transplant 30 (2015), 223–233.
45. Rutkowski, J.M., Markhus, C.E., Gyenge, C.C., et al. Dermal collagen and lipid deposition correlate with tissue swelling and hydraulic conductivity in murine primary lymphedema. Am J Pathol 176 (2010), 1122–1129.
46. Woo, S.M., Rosser, J., Dusevich, V., et al. Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo. J Bone Miner Res 26 (2011), 2634–2646.
47. Wang, X., Nyman, J., Dong, X., et al. Fundamental Biomechanics in Bone Tissue Engineering. 2010, Morgan & Claypool Publishers, San Rafael, California.